589 related articles for article (PubMed ID: 28975829)
1. Liver-Directed Therapies for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
Kis B; El-Haddad G; Sheth RA; Parikh NS; Ganguli S; Shyn PB; Choi J; Brown KT
Cancer Control; 2017; 24(3):1073274817729244. PubMed ID: 28975829
[TBL] [Abstract][Full Text] [Related]
2. Transarterial chemoembolization for primary liver malignancies and colorectal liver metastasis.
Miura JT; Gamblin TC
Surg Oncol Clin N Am; 2015 Jan; 24(1):149-66. PubMed ID: 25444473
[TBL] [Abstract][Full Text] [Related]
3. Liver-directed therapy for hepatocellular carcinoma.
Narsinh KH; Duncan DP; Newton IG; Minocha J; Rose SC
Abdom Radiol (NY); 2018 Jan; 43(1):203-217. PubMed ID: 29230556
[TBL] [Abstract][Full Text] [Related]
4. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
Yin X; Zhang BH; Qiu SJ; Ren ZG; Zhou J; Chen XH; Zhou Y; Fan J
Ann Surg Oncol; 2012 Sep; 19(9):2869-76. PubMed ID: 22451237
[TBL] [Abstract][Full Text] [Related]
5. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective.
Poon RT; Fan ST; Tsang FH; Wong J
Ann Surg; 2002 Apr; 235(4):466-86. PubMed ID: 11923602
[TBL] [Abstract][Full Text] [Related]
6. How does selective internal radiation therapy compare with and/or complement other liver-directed therapies.
Bargellini I
Future Oncol; 2014 Nov; 10(15 Suppl):105-9. PubMed ID: 25478780
[No Abstract] [Full Text] [Related]
7. Treating unresectable intrahepatic cholangiocarcinoma with transarterial chemoembolization and an unusual progression with cardiac involvement.
Mumdzhiev N; Borisov B; Tenev R; Radicheva M
Folia Med (Plovdiv); 2023 Apr; 65(2):326-330. PubMed ID: 37144321
[TBL] [Abstract][Full Text] [Related]
8. [Local and locoregional treatment of intrahepatic cholangiocarcinoma].
Wacker F; Dewald C
Radiologe; 2022 Mar; 62(3):247-252. PubMed ID: 34981129
[TBL] [Abstract][Full Text] [Related]
9. Management of Hepatocellular Carcinoma: Current Status and Future Directions.
Au JS; Frenette CT
Gut Liver; 2015 Jul; 9(4):437-48. PubMed ID: 26087860
[TBL] [Abstract][Full Text] [Related]
10. Arterially directed therapies for hepatocellular carcinoma.
Shah RP; Brown KT; Sofocleous CT
AJR Am J Roentgenol; 2011 Oct; 197(4):W590-602. PubMed ID: 21940531
[TBL] [Abstract][Full Text] [Related]
11. [Regional therapy of liver tumors].
Spangenberg HC; Mohr L; Blum HE
Internist (Berl); 2007 Jan; 48(1):40-5. PubMed ID: 17160664
[TBL] [Abstract][Full Text] [Related]
12. Transarterial radioembolization for liver tumors as neoadjuvant therapy: three case reports.
Carvalho VO; Galastri FL; Affonso BB; Falsarella PM; Valle LGM; Ferraz-Neto BH; Rezende MB; Motta-Leal-Filho JMD; Garcia RG; Nasser F
Einstein (Sao Paulo); 2020; 18():eRC4990. PubMed ID: 32130329
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma.
Golfieri R; Bilbao JI; Carpanese L; Cianni R; Gasparini D; Ezziddin S; Paprottka PM; Fiore F; Cappelli A; Rodriguez M; Ettorre GM; Saltarelli A; Geatti O; Ahmadzadehfar H; Haug AR; Izzo F; Giampalma E; Sangro B; Pizzi G; Notarianni E; Vit A; Wilhelm K; Jakobs TF; Lastoria S;
J Hepatol; 2013 Oct; 59(4):753-61. PubMed ID: 23707371
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant therapy for hepatocellular carcinoma after curative treatment.
Jeng WJ; Lin CC; Chen WT; Sheen IS; Lin CY; Lin SM
Dig Dis; 2014; 32(6):747-54. PubMed ID: 25376293
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in the treatment of hepatocellular carcinoma.
Padhya KT; Marrero JA; Singal AG
Curr Opin Gastroenterol; 2013 May; 29(3):285-92. PubMed ID: 23507917
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma locoregional therapies: Outcomes and future horizons.
Makary MS; Ramsell S; Miller E; Beal EW; Dowell JD
World J Gastroenterol; 2021 Nov; 27(43):7462-7479. PubMed ID: 34887643
[TBL] [Abstract][Full Text] [Related]
17. Chemoembolization and bland embolization: a critical appraisal.
Befeler AS
Clin Liver Dis; 2005 May; 9(2):287-300, vii. PubMed ID: 15831274
[TBL] [Abstract][Full Text] [Related]
18. Surgical resection and liver transplantation for hepatocellular carcinoma.
Akoad ME; Pomfret EA
Clin Liver Dis; 2015 May; 19(2):381-99. PubMed ID: 25921669
[TBL] [Abstract][Full Text] [Related]
19. Liver-directed therapies for hepatocellular carcinoma.
Arciero CA; Sigurdson ER
J Natl Compr Canc Netw; 2006 Sep; 4(8):768-74. PubMed ID: 16948955
[TBL] [Abstract][Full Text] [Related]
20. Transarterial Chemoembolization and (90)Y Radioembolization for Hepatocellular Carcinoma: Review of Current Applications Beyond Intermediate-Stage Disease.
Fidelman N; Kerlan RK
AJR Am J Roentgenol; 2015 Oct; 205(4):742-52. PubMed ID: 26397322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
